Abzena Plc
Address: Babraham Research Campus, Cambridge, CB22 3ATSocial Media
LinkedIn :About Us
Abzena is a life sciences group with its headquarters in the UK and two sites in the US.
Abzena offers a range of complementary services and technologies for the selection, development and manufacture of biopharmaceuticals, products based on antibodies or other proteins.
Abzena’s range of services and technologies include:
- Antibody discovery and candidate screening
- Immunology and immunogenicity assessment
- Antibody and protein engineering to reduce immunogenicity
- Bioconjugation to produce antibody-drug conjugates and optimise pharmacokinetics
- Custom synthesis of cytotoxic paylods, reagents and other small molecules
- Manufacture of payoad linkers and antibody-drug conjugates
- Development of manufacturing cell lines and process development
- Manufacture of biopharmaceuticals for Phase I and II clinical studies
Sectors
- Proprietary Research & Manufacture
- Contract Manufacturing
- Contract Research & Development
Categories
- Biologics
- BioPharmaceuticals
- Biotechnology
- Antibodies-monoclonals
- Antibodies-Bi-specific-Multi-specific
- Antibodies-Fusion
- Immunology
- Proteins
- Peptides
- Bioprocess Development
- Antibody Drug Conjugates
- Bioconjugation
- Drug Conjugates & Linkers
- ADC-Payload
- Mammalian cell culture manufacturing
- Cell Culture Technology
- Cell Line Development
- Proteins-Recombinant
- Cell Therapy Products
- PEGylation
- Cytokines
- Continuous Manufacturing
- Continuous Chromatography
A PHP Error was encountered
Severity: Notice
Message: Undefined property: stdClass::$company_licence_detail_in
Filename: profile/print_profile.php
Line Number: 302
Backtrace:
File: /home/pharmase/actex_application/views/front_end/profile/print_profile.php
Line: 302
Function: _error_handler
File: /home/pharmase/actex_application/controllers/Profile.php
Line: 483
Function: view
File: /home/pharmase/public_html/index.php
Line: 292
Function: require_once
A PHP Error was encountered
Severity: Notice
Message: Undefined property: stdClass::$company_licence_detail_out
Filename: profile/print_profile.php
Line Number: 303
Backtrace:
File: /home/pharmase/actex_application/views/front_end/profile/print_profile.php
Line: 303
Function: _error_handler
File: /home/pharmase/actex_application/controllers/Profile.php
Line: 483
Function: view
File: /home/pharmase/public_html/index.php
Line: 292
Function: require_once
A PHP Error was encountered
Severity: Notice
Message: Undefined property: stdClass::$company_licence_detail_distributor
Filename: profile/print_profile.php
Line Number: 304
Backtrace:
File: /home/pharmase/actex_application/views/front_end/profile/print_profile.php
Line: 304
Function: _error_handler
File: /home/pharmase/actex_application/controllers/Profile.php
Line: 483
Function: view
File: /home/pharmase/public_html/index.php
Line: 292
Function: require_once
A PHP Error was encountered
Severity: Notice
Message: Undefined property: stdClass::$company_licence_detail_researcher
Filename: profile/print_profile.php
Line Number: 305
Backtrace:
File: /home/pharmase/actex_application/views/front_end/profile/print_profile.php
Line: 305
Function: _error_handler
File: /home/pharmase/actex_application/controllers/Profile.php
Line: 483
Function: view
File: /home/pharmase/public_html/index.php
Line: 292
Function: require_once
A PHP Error was encountered
Severity: Notice
Message: Undefined property: stdClass::$company_licence_detail_description
Filename: profile/print_profile.php
Line Number: 306
Backtrace:
File: /home/pharmase/actex_application/views/front_end/profile/print_profile.php
Line: 306
Function: _error_handler
File: /home/pharmase/actex_application/controllers/Profile.php
Line: 483
Function: view
File: /home/pharmase/public_html/index.php
Line: 292
Function: require_once
News
Abzena & Argonaut Partner to Offer Accelerated End-to-End Drug Development Support
San Diego, CA, June 20, 2024 – Abzena, the leading end-to-end integrated contract and development manufacturing organization (CDMO) for complex biologics and bioconjugates, and Argonaut Manufacturing Services, Inc., a cGMP CDMO serving the biopharmaceutical and diagnostics industries, announced a strategic partnership to provide a fully integrated drug substance and drug product manufacturing solution for biopharmaceutical organizations. This alliance offers a streamlined approach for customers looking to rapidly progress therapies into the clinic, or onward into later-stage commercial manufacturing.
Abzena Partners with ProteoNic to Offer Enhanced CHO Cell Line
San Diego, CA, December 5, 2023 – Abzena, the leading end-to-end bioconjugate and complex biologics CDMO has announced a partnership with ProteoNic Biosciences BV, to license their premium protein expression technology, 2G UNic®. This state-of-the-art vector technology will significantly improve the production of high-yielding CHO cell lines for Abzena’s customers.
Abzena blueprints $200M biologics plant in North Carolina, where it plans to hire 325
Abzena is a Global Partner Research Organization (PRO) specializing in the integrated development and manufacture of complex biologics and bioconjugates has announced that the location of its new GMP manufacturing facility will be Sanford, North Carolina. The significant expansion of Abzena’s capacity is driven by an increase in customer demand for commercial scale 2000L single use bioreactors across a wide range of therapeutic areas. Sanford will be Abzena’s 6th site in a global network providing integrated solutions and will be dedicated to cGMP manufacturing capacity for mammalian biologics.
Source: The Partnership Tree | https://www.pharmaservicesdirectory.com